D&D Pharmatech is staging a strong rally, recording an increase of more than 8% during trading. As investment sentiment in bio stocks has recently recovered overall, buying pressure is flowing in, and trading volume is rapidly increasing, drawing keen market attention.

During the morning session on the 1st, D&D Pharmatech is trading at 95,000 won, up 7,400 won from the previous trading day. The gain exceeds 8%, charting a clear upward curve. Buy orders continued from early in the session, pushing the stock price past the 94,000-won range and approaching the 95,000-won level.

Market analysts note that amid a trend of improving investment sentiment across the broader bio sector, buying interest is spreading centered on stocks with highlighted growth potential. In particular, D&D Pharmatech continues to attract investor attention as expectations regarding its new drug development pipeline and its mid- to long-term growth potential are consistently discussed.

With today's sharp surge, D&D Pharmateck has further reinforced its recent upward momentum. Whether the increase in trading volume and changes in supply and demand will persist is expected to be the key variable determining the short-term direction of the stock price.

[This article was written with the assistance of AI. This article does not constitute investment advice, and the final decision and responsibility for investments lie solely with the investor.]